Isthmus Partners’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-3,009
Closed -$572K 144
2019
Q1
$572K Sell
3,009
-19,478
-87% -$667K 0.14% 112
2018
Q4
$756K Buy
22,487
+3,621
+19% +$131K 0.23% 98
2018
Q3
$796K Buy
18,866
+534
+3% +$21.1K 0.2% 95
2018
Q2
$587K Buy
18,332
+1,427
+8% +$58.8K 0.15% 105
2018
Q1
$841K Buy
16,905
+495
+3% +$28K 0.23% 82
2017
Q4
$885K Buy
16,410
+89
+0.5% +$4.93K 0.24% 78
2017
Q3
$947K Buy
16,321
+55
+0.3% +$2.88K 0.27% 69
2017
Q2
$803K Sell
16,266
-62
-0.4% -$2.85K 0.23% 82
2017
Q1
$709K Buy
16,328
+337
+2% +$16.1K 0.21% 89
2016
Q4
$783K Sell
15,991
-285
-2% -$13.2K 0.24% 78
2016
Q3
$758K Sell
16,276
-12
-0.1% -$593 0.24% 69
2016
Q2
$874K Sell
16,288
-453
-3% -$21.3K 0.29% 54
2016
Q1
$749K Sell
16,741
-51
-0.3% -$2.07K 0.25% 63
2015
Q4
$641K Buy
+16,792
New +$642K 0.22% 79

Other funds holding ANIK